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The significance of learned food aversions in the aetiology of anorexia
associated with cancer
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Departnment of Nutrition, Kings College (f/rmerljy Queen Elizabeth College), Campden Hill Road, London W8 7AH, UK.
Summary The results of 24 h food preference tests have suggested that learned food aversions may be
involved in the development of anorexia in tumour bearing rats and in patients with cancer. We have
performed similar tests over longer periods, up to 10 days, in male rats implanted with Leydig cell tumours,
using semisynthetic diets containing differing proportions of fat, protein and carbohydrate.
Tumour growth caused anorexia (16-30% decrease in food intake) and cachexia (78% decrease in body fat
and 18% decrease in body protein, but 16% increase in body water). Both tumour bearing and control rats
preferred a high carbohydrate diet to a high fat diet regardless of their previous diet: tumour bearing rats
showed no evidence of a learned food aversion in these experiments. Tumour bearing rats did show an initial
preference for a novel high protein diet when this was offered as an alternative to the normal protein diet
they had previously been consuming, but this apparent learned food aversion disappeared on the second day
of the test and was in fact reversed on all the subsequent days of the test. However, tumour bearing rats did
show a sustained preference for a novel low protein diet when this was offered as an alternative to the normal
protein diet they had previously been consuming. These results suggest that anorexia in the tumour bearing
rats was not caused by a learned food aversion. However the results do indicate that the tumour bearing rats
may have developed a specific aversion to protein in the diet.
Leydig cell tumours are known to secrete large amounts of oestradiol. However injections of oestradiol in
normal male rats caused an increase in body fat content and had no effect on the rats' preference for dietary
protein. Clearly hypersecretion of oestradiol was not responsible for the loss of body fat, the fluid retention
and the aversion to dietary protein which characterised the tumour bearing rats. The mechanisms by which
tumour growth causes anorexia and cachexia in these rats remains obscure. *
The major cause of death in patients with cancer is the existence of learned food aversions for periods up to ten
generalised body wasting known as cachexia. This syndrome days in tumour bearing rats. Since it became clear during
is characterised by abnormally low food intake together with these studies that factors other than previous diet were
inappropriately high energy expenditure. Although much is governing the sustained food preference of our tumour
now known about the metabolic abnormalities which bearing rats we examined systematically their preferences for
underlie the elevation of energy expenditure, considerably the major components of the semisynthetic diets we were
less is known about the decrease in food intake which many using, viz. protein, fat and carbohydrate.
workers now regard as the primary event in the onset of Bernstein and Fenner (1983) found that these food
cancer cachexia (Lindmark et al., 1984; Morrison, 1979). aversions did not occur in all tumour bearing rat models. We
One feature of cancer anorexia which has been studied in therefore conducted our studies using a transplantable
both man and the rat is the occurrence of 'learned food Leydig cell tumour growing in Fischer F344 rats. This
aversions'. A learned food aversion is the unconscious should correspond closely with the transplantable Leydig cell
association (by a person or an animal) of the consumption tumour growing in Wistar-Furth rats in which Bernstein and
of a particular food with a concurrent or subsequent Fenner (1983) were able to demonstrate short term food
unpleasant reaction. Thus a cancer-bearing rat comes to aversions. We monitored the growth rate, total food intake
associate the growth of the tumour with the diet which it has and body composition of the rats to ascertain that this was a
consumed during tumour growth, and if it is then offered a suitable model for the anorexia and cachexia of human
choice between this diet and a different diet it shows an cancer. In some of the studies we used Sprague-Dawley rats,
immediate preference for the new diet (Bernstein & which were more readily available, when we found that the
Sigmundi, 1980). The introduction of this new diet also tumour grew equally well in them and had the same effects
causes at least a transient increase in total food con- on food intake and body composition. The Leydig cell
sumption. Similar studies in man have shown that when tumour is known to secrete large quantities of oestrogens, so
children and adults with cancer were given a distinctively we examined the extent to which this could account for any
flavoured ice-cream immediately prior to a dose of chemo- of the effects observed in the tumour bearing rats by
therapy they developed an unconscious aversion to that administering exogenous oestradiol to normal rats.
flavour of ice-cream (Bernstein & Webster, 1980).
Subsequent studies have identified aversions to many normal
components of patients' regular diets (Bernstein & Bernstein, Materials and methods
1981).
These studies have only investigated food preference at a Animals
single meal (in cancer patients) or over a single day (in
tumour bearing rats). If learned food aversions do play a Male Fisher F344 rats from OLAC Ltd (Bicester, Oxon.)
causal role in the aetiology of cancer anorexia they must weighing 180-200g were used in Experiments 1 and 2; male
presumably continue to exist for as long as the patient or Sprague-Dawley rats from the QEC colony (this institute)
animal remains anorectic. We have therefore monitored the weighing 150-170g were used in Experiments 3-5. The rats __________________________________________ were housed individually in wire-bottomed cages suspended
*Present address: Department of Medicine, Royal Free Hospital. over trays to facilitate collection of spilled food and given
Pond Street, London NW3 2QG, UK. free access to water and a semisynthetic diet (see below).
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for at least two days, and were continued for ten days. At Table I Composition of diets (%)
the end of each experiment the rats were killed, the whole
gut from stomach to rectum was removed and its contents Diet NP HP LP HF LF
flushed out, and tumours and representative organs were Casein 15 45 5 20 20
dissected out and weighed. The carcasses, including the Maize starch 35 4 45 10 60
weighed organs but not the tumours, were then analysed for Sucrose 30 30 30 0 0
water, by oven drying, protein, by the Kjeldahl method, and Maize oil 10 10 10 27 5
energy, by ballistic bomb calorimetry: body fat content was Cellulose 4 4 4 33 5
calculated by applying gross energy values for protein and Mineral mixa 4 4 4 4 4
fat of 22.7 and 38.6 kJg-1 respectively (Djazayery et al., Vitamin mix' 2 2 2 2 2
1979).
aSee Bernhart and Tomarelli (1966); bSee Naismith
Tumour et al. (1969).
Tumour cells were originally supplied by Dr C. Dix (Royal
Free Hospital School of Medicine, London) from a Leydig Tomas et al. (1979). The doses were 0.1, 0.01, 0.001 and
cell tumour which has been described previously (Cooke et 0 mg per day for groups A, B, C and D respectively. All the
al., 1978). The tumour was then maintained by passaging cell rats were fed ad libitum on diet NP for 11 days and then
suspensions serially in Sprague-Dawley rats. When a tumour given a food preference test (as in Experiment 1) between
weighed 1O g the rat was killed and the tumour excised. diets NP and HP from day 12-21. On day 22 the rats were
Pink tissue from the periphery of the tumour was scraped off anaesthetised by i.p. injection of sodium pentobaritone
and suspended in Dulbecco's modified Eagle's medium, (Sagatal, 60 mgkg- I body wt) and blood was taken by
supplemented with 0.1% bovine serum albumin and buffered cardiac puncture for analysis of oestradiol content by radio-
at pH 7.4 with 10mM HEPES, at 37°C. Large lumps were immunoassay kit (Steranti Research Ltd, St Albans, Herts).
dispersed by repeated aspiration through a 2.8 mm cannula.
The suspension was then filtered through a 60pm nylon Statistics
mesh, centrifuged for 10min at 100g, and the precipitated
cells resuspended in fresh medium. I ml portions of this The statistical significance of differences in diet preference
suspension (containing 106 cells)- were then injected s.c. between tumour bearing and control rats was evaluated
into each flank of other rats. using the Mann-Whitney test. The statistical significance of
other differences was assessed using Student's t-test. A
Experimental protocols probability level of less than 0.05 was considered to be
Experiment I Nine rats were injected with suspensions of g
tumour cells and 7 were given sham injections of the cell
culture medium only. The rats were then fed ad libitum on a Results
15% casein diet (NP - see Table I) for 25 days. Tumours
became palpable on day 21. From day 26-35 the rats were Body composition and totalfood intake
offered an isocaloric 45% casein diet (HP - see Table I) in
addition to the NP diet. Identical pots containing the two Figures 1 and 2 show the body weights and total food
different diets were placed in separate corners of the cage to intakes of rats in a typical experiment (Experiment 3). Food
facilitate identification of the spillage from the two diets, and intake began to fall just before the tumours became palpable
intake of each diet was thus measured each day. Positioning (day 17), and the food preference test was started 4 days
of the diets was alternated from rat to rat, but was kept the later. During the period of detectable tumour growth the
same from day to day. Prior to this food preference test the
single diet pot had been placed in the middle of the cage.
280
Experiment 2 Nine rats were injected with suspensions of
tumour cells and 7 were given sham injections of the cell
culture medium only. The rats were then fed ad libitum on 260
the 15% casein diet (NP) for 40 days. Tumours became
palpable on day 37. From day 41-50 the rats were given a
food preference test (as in Experiment 1) between diet NP 240
and an isocaloric 5% casein diet (LP - see Table 1).
Experiment 3 Eight rats were injected with suspensions of m 220
tumour cells and 8 were given sham injections of the cell
culture medium only. The rats were then fed ad libitum on a
high fat, low carbohydrate diet (HF) for 20 days. Tumours B 200/
became palpable on day 17. From day 21-30 the rats were
given a food preference test (as in Experiment 1) between
diet HF and an isonitrogenous low fat, high carbohydrate 180
diet (LF - see Table I).
Experiment 4 Eight rats were injected with suspensions of 160_
tumour cells and 8 were given sham injections of the cell
culture medium only. The rats were then fed ad libitum on
diet LF for 20 days. Tumours became palpable on day 17. 140 10 20 30
From day 21-30 the rats were given a food preference test Time (days)
(as in xperimnt 1) btween iets LFand HF Figure 1 Mean body weights of tumour bearing --- and
control -rats in a typical experiment (Experiment 3)..
Experiment 5 Twenty-four rats were randomly allocated to represents the calculated values for the weight of the host tissues
4 groups of 6. Each rat was then given daily s.c. injections of of the tumour bearing rats, assuming linear tumour growth from
oestradiol suspended in a slow-release vehicle as described by day 17, when the tumour became palpable.FOOD AVERSION IN CANCER ANOREXIA 75
20- Table II Organ weights and body composition of tumour
bearing and control rats from Experiments 1-4. Values are
mean +s.e.
Tumour bearing Control
15 Organ weights
Gastrocnemius muscle (g) 1.12+0.02a 1.41+0.03
3. 'i / Liver (g) 11.30+0.19a 10.30+0.20
Small intestine (g) 6.18+0.1la 8.34+0.16
Heart (g) 0.89+0.01 0.89+0.02
Tumour (g) 20.10+0.32
lo - n 34 30
C
._ Body composition
0 Carcass weight (g) 272+4 281+ 3
E_ Water (g) 206+7a 177+7
Protein (g) 42.6+ 1.4a 52.4+2.0
5 Fat (g) 7.6+0.7a 36.2+ 1.4
n 8 8
aSignificantly different from control, P<0.05.
00 10 20 30 tumour bearing animals. Tumour bearing rats contained
Time (days) 18% less protein and 78% less fat but 16% more water than
Figure 2 Mean daily food intakes of tumour bearing . and controls. The wasting of skeletal muscle and hypertrophy of
control rats in a typical experiment (Experiment 3). the liver, together with the overall loss of body fat and
protein and fluid retention, are typical features of cancer
cachexia in man and animals (Lundholm et al., 1980; Nixon
tumour bearing rats ate 16% less food than sham injected et al., 1980). The atrophy of the gut may be partly a simple
controls (P<0.01). In other experiments the deficit in food mechanical result of decreased food intake, but may also
intake was between 20-30% (P<0.01 in all cases). The represent mobilisation of amino acids from smooth muscle
length of time between injection of tumour cells and the start protein in response to the same stimulus that causes
of detectable tumour growth varied considerably between breakdown of skeletal muscle protein, as happens during
experiments but was very consistent between rats within an starvation (Emery et al., 1986). Cardiac muscle, however,
experiment. The variation may have been caused by appears to be relatively protected from wasting during
differences in the concentration of tumour cells in the cancer cachexia, as it is in starvation (Emery et al., 1983).
suspension prepared at the start of each experiment for The effects of tumour growth on body weight, food intake
injecting into the rats. and body composition of the rats in these experiments was
The growth of the tumour was always accompanied by a similar to the effects observed in similar rats maintained
reduction in food intake but the rate of total body weight entirely on diet NP (Emery et al., unpublished observations).
gain was not always reduced. This was partly because the Table III summarises the effects of administation of
loss of host tissue was to some extent offset by the growth of oestradiol to normal male rats. The plasma oestradiol
the tumour, but also because the tumour bearing rats were concentration of group A rats (1040 +400 pgml-1) was not
retaining excessive amounts of fluid (Table II). Clearly the significantly different from that of tumour bearing rats
rate of loss of body weight will not always be a reliable (1030+250pgml-1). This dose of oestradiol caused a 17%
guide to the extent of cachexia in human cancer patients reduction in food intake but only a 7% reduction in weight
who may also retain fluid. gain. Moreover the body composition of the oestradiol
Table II summarises the effect of tumour growth on host treated rats was quite different from that of either normal
body composition in the animals from Experiments 1-4. The rats or tumour bearing rats. Protein content was reduced by
tumour represented only 7.4% of the animal's final body 17% but fat content was increased by 72% in group A
weight. Skeletal muscle was severely wasted, as shown by the compared with control rats. Thus whereas the reduction in
20% reduction in gastrocnemius muscle weight of tumour food intake and loss of lean body mass by tumour bearing
bearing rats compared with controls. There was also a 26% rats might be partially attributable to the effect of oestradiol
reduction in the weight of the small intestine. In contrast, the massive loss of fat is obviously not. Oestrogen adminis-
there was no difference in heart weight between the two tration has previously been reported to reduce food intake
groups, while liver weight showed a 10% increase in the and weight gain in intact male rats (Moffitt et al., 1975),
Table III Body composition, food intake and plasma oestradiol concentration of normal male
rats treated with daily s.c. injections of oestradiol (Experiment 5). Values are mean +s.e. for 6
rats per group
Group A B C D
Oestradiol dose (,ug/day) 100 10 1 0
Initialbodyweight(g) 160+3 160+4 161+3 161+4
Final body weight (g) 225+5 230+5 235+5 234+4
Carcass water (g) 131 +Sa 136+7 136+4 148+2
Carcass protein (g) 35.3+ 1.7a 37.9+ 1.9 40.7+ 1.9 42.6+ 1.1
Carcass fat (g) 29.4+ 1.Oa 27.3+ 1.3a 25.6+ 1.2a 17.1 +0.9
Food intake(g/21 days) 283+9a 303+7 321+10 340+13
Plasma oestradiol (pgml-) 1040+400a 183+65 30+ 16 5+3
aSignificantly different from Group D, P<0.05.76 J.A. LEVINE & P.W. EMERY
possibly acting via an increase in corticosterone production 100
(Mook et al., 1972), but the effect on body composition has
not previously been reported. On the other hand oestrogen 90 -
administration is known to increase fat deposition in farm
animals, but this is always associated with increased growth 80
rate and food intake (Galbraith & Topps, 1981).
70_
Foodpreference tests
Figure 3 shows the results of the food preference test on 60
each day of Experiment 1. Diet preference is indicated by the
proportion of total food intake which came from diet NP. Z 50_
On the first day of the test the tumour bearing rats R
consumed considerably more of the novel diet HP than the 40
'home' diet NP while the sham injected controls consumed
roughly equal amount of the two diets. Although the 30
difference in diet preference between the two groups was not
statistically significant the trend was in the direction that 20
would have been expected if the tumour bearing rats had
indeed developed a learned aversion to their previous diet 10_
NP. On the second day of the test both groups ate roughly
cqual amounts of the two dicts, and there was again no 0
significant difference in diet preference between the two 1 2 3 4 5 6 7 8 9 10
groups. However on each of days 3-10 the tumour bearing Time(days)
rats ate more NP than HP, while the controls continued to Figure 4 Mean preference for diet NP (as % of total food eaten
eat approximately equal amounts of the two diets. The each day) of tumour bearing fl and control rats
difference in diet preference between the two groups was which had been fed on NP prior to being offered a choice
statistically highly significant on each of these days. Over the between NP and LP (Experiment 2).
whole 10 day period the tumour bearing rats consumed 81%
of their food as NP, compared with 51% for the controls
(P<0.01). statistically significant difference in food preference between
The apparent learned food aversion shown by the tumour the two groups on each of days 2-10; overall the tumour
bearing rats was thus only a transient phenomenon. In the bearing rats consumed 18% of their food as NP compared
longer term they actually showed a sustained preference for with 47% for the controls (P<0.01). These results suggest
the familiar diet NP. This could be interpreted as a 'home that the tumour bearing rats had in fact developed a specific
diet preference' or it could indicate a specific aversion to aversion to dietary protein.
dietary protein in tumour bearing rats. These possibilities Experiments 3 and 4 were designed to investigate whether
were therefore evaluated in Experiment 2 by testing tumour growth was associated with aversions to the other
preference for a novel low protein diet against the familiar major nutrients in the diet, fat and carbohydrate. As shown
diet NP. As shown in Figure 4 the tumour bearing rats in Figures 5 and 6 there was no consistent difference
showed a sustained preference for the novel diet LP through- between tumour bearing and control rats in their preference
out this experiment, whereas the controls showed an initial for HF and LF diets. All animals showed a sustained
preference for LP on day I but then ate approximately equal preference for the low fat, high carbohydrate diet LF,
amounts of the two diets on each of days 2-10. There was a regardless of which diet had been fed previously. In fact the
100 ° 100
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80 2 80
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Figure 3 Mean preference for diet NP (as % of total food eaten Figure 5 Mean preference for diet HF (as % of total food eaten eahday) of tumour bearing t -:: and control rats each day) of tumour bearing E ;- :- and control rats which had been fed on NP prior to being offered a choice which had been fed on HF prior to being offered a choice
between NP and HP (Experiment 1). between HF and LF (Experiment 3).FOOD AVERSION IN CANCER ANOREXIA 77
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Figure 6 Mean preference for diet HF (as % of total food eaten Figure 7 Mean preference for diet NP (as % of total food eaten
each day) of tumour bearing [ n and control rzz rats each day) of normal rats given injections of 0.1 L , 0.01
which had been fed on LF prior to being offered a choice o', 0.001 . and 0 mg per day oestradiol. All
between HF and LF (Experiment 4). rats had been fed NP for 11 days prior to being offered a choice between HP and NP (Experiment 5).
tumour bearing rats did eat significantly less HF than the longer than 24 hours: the present results cast doubt on the
controls on day 3 of Experiment 4 (P<0.05) and aetiological significance of those observations.
significantly more HF than the controls on day 6 of the The major change in food preference which the tumour
same Experiment (P<0.05). There was no obvious reason bearing rats showed was an aversion to a high protein diet
for this anomalous behaviour on those days, and it does not and a preference for a low protein diet. In fact the protein
alter the interpretation of the results. In Experiment 3 the source used in the diets was not pure protein but also
tumour bearing rats ate, on average, 14% of their food as contained 1% fat, 2% lactose and 8% minerals, so it is not
HF while the controls ate 18% HF (P=NS), and in impossible that the rats were actually trying to avoid one of
Experiment 4 the tumour bearers ate 22% HF while the these components. However it is much more likely that the
controls ate 24% HF (P=NS). Clearly tumour growth had tumour bearing rats were showing an aversion to dietary
no effect on the rats' choice between these two iso- protein, and this may correspond to reports of human cancer
nitrogenous diets. patients developing a distaste for high protein foods,
Experiment 5 was designed to investigate whether the particularly meat (De Wys, 1970).
aversion to a high protein diet shown by the tumour bearing Tumour bearing rats did not show any altered preference
rats in Experiment 1 was caused by the high circulating for the major sources of energy in their diets, carbohydrate
concentration of oestradiol. Figure 7 shows that this was not and fat. Both tumour bearers and controls showed a marked
the case, since there was in fact no significant difference in preference for diet LF rather than HF. This may have been
food preference between any of the groups of rats on any caused by the large amount of cellulose which was present in
day. Over the 10 day test period the rats in group A, which HF in order to make the metabolisable energy density of
received the highest dose of oestradiol, consumed 55% of these two diets equal. Large amounts of cellulose and other
their food as NP, compared with 54% for group B, 47% for 'dietary fibres' can cause distension of the gastrointestinal
group C, and 51% for the control group D. Clearly the tract and abdominal discomfort.
effect of this Leydig cell tumour on food preference which The significance of these results for human cancer patients
was observed in Experiment 1 was not mediated simply by depends to some extent on how closely this animal model
hypersecretion of oestradiol. mimics the features of human cancer cachexia. Probably the
most important point is that the tumour should not be too
Discussion large in proportion to the host animal, since human tumours
rarely grow to more than 5% of body weight (Costa, 1977).
The results of these experiments do not support the The tumours we used in these studies grew to 8% of the
hypothesis that learned food aversions are important in the host body weight by the end of the experiments and caused a
development of the anorexia which is characteristic of cancer sustained depression of food intake and a severe loss of
cachexia. The results of the first day of Experiment 1 could protein and fat from the host body. This was thus a more
have been interpreted as showing the existence of a learned appropriate model than, for instance, the most widely used
food aversion in the tumour bearing rats but the subsequent animal tumour model, the Walker 256 carcinoma growing in
behaviour of these rats showed that this was only a transient Sprague-Dawley rats, which can grow to more than 40% of
phenomenon. The consistent preference of these rats for diet host body weight (Mider et al., 1948).
NP throughout days 2-1O was the opposite of what would The mechanism by which tumour growth causes changes
have been observed if a learned food aversion had been in food preferences remains obscure, as indeed is the case for
responsible for the anorexia caused by tumour growth. other features of cancer cachexia. The main identifiable
Previous investigations of learned food aversions in tumour humoral products secreted by Leydig cell tumours are
bearing rats and patients (Bernstein & Sigmundi, 1980; oestrogens, but Experiment 5 showed that raising the plasma
Bernstein & Webster, 1980) did not test food preference for oestradiol concentration of normal rats to a level78 J.A. LEVINE & P.W. EMERY
comparable to that of the tumour bearing animals did not
have the same effect on food preference or body composition
as tumour growth. If the anorexia and cachexia of cancer are
indeed mediated through an as yet unidentified humoral
substance it may be that this substance is in fact synthesised
by host tissues in response to the presence of the tumour
rather than by the tumour itself (Editorial, 1985).
We are grateful to the Cancer Research Campaign and the Nuffield
Foundation for financial support.
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